Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamuel Heath Regulatory News (HSM)

Share Price Information for Samuel Heath (HSM)

Share Price is delayed by 15 minutes
Get Live Data
325.00    0.00 (0.00%)
Bid:
310.00
Ask:
340.00
Spread: 30.00 (9.677%)
Market Cap: £8.24m
HSM Live PriceLast checked at - London Stock Exchange

Intraday Samuel Heath Share Chart

Final Results

11 Jul 2019 07:00

RNS Number : 1536F
Heath(Samuel) & Sons PLC
11 July 2019
 

 

 

 

HEATH (SAMUEL) & SONS PLC

 

11th JULY 2019

 

PRELIMINARY RESULTS FOR THE YEAR ENDED 31ST MARCH 2019

 

CHAIRMAN'S STATEMENT

 

It is pleasing to report the results for the year, in which revenue was a little down, but underlying operating profits improved.

 

Sales revenue was £13.89m (2018: £14.35m) and profit before tax was £0.88m (2018: £1.18m). This was after the exceptional item for Guaranteed Minimum Pension (GMP) Equalisation relating to our pension fund which we have had to recognise this year. The operating profit was better than last year at £1.38m (2018: £1.34m) reflecting savings made through overheads.

 

As I am certain shareholders are aware, this year has been the same as the one before with regard to trading conditions. The uncertainty around Brexit has caused us all sorts of continuing problems. These are perhaps surprisingly not led by uncertainty of sales to business customers within the EU, but much more seriously from our supplies from there. It is having, most importantly of all, a very bad effect on our business, and our future prospects, with our London and South Eastern customers within the UK.

 

It is therefore more difficult than ever to forecast where we might be in twelve months' time. You can imagine that I do not enjoy being so indecisive, but it is a unique situation we find ourselves in. Perhaps I could add, as a company listed on the London Stock Exchange since 1890, there must have been other times equally difficult, which we managed to get through.

 

Having said that, overall business activity has held up well up to the time of writing this statement. This has undoubtedly been helped by our considerable investment in some excellent designs and products, together with that in plant, machinery and IT systems in order to manufacture them efficiently.

 

Our current profitability allows us to recommend, in addition to the interim dividend of 5.5p per share which was paid 23rd March 219, a final dividend at the same level as last year, at 6.875p per share, which will be paid on 16th August 2019 to shareholders registered as at 19th July 2019.

 

 

Sam Heath

Chairman

10th July 2019

 

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

For further information:

 

Samuel Heath & Sons Plc

 

Simon Latham - Company Secretary

+44 (0)121 766 4200

 

 

Cairn Financial Advisers LLP

+44 (0)20 7213 0880

James Caithie/Jo Turner

 

 

 

 

CONSOLIDATED INCOME STATEMENT FOR THE YEAR ENDED 31st MARCH 2019

 

 

 

 

 

 

 

 

 

 

 

Note

 

2019

 

 

2018

 

 

 

£000

 

 

£000

 

 

 

 

 

 

 

Revenue

3

 

13,893

 

 

14,354

 

 

 

 

 

 

 

Cost of sales

 

 

(7,125)

 

 

(7,232)

 

 

 

 

 

 

 

Gross profit

 

 

6,768

 

 

7,122

 

 

 

 

 

 

 

Selling & distribution costs

 

 

(3,474)

 

 

(3,767)

Administrative expenses

 

 

(1,915)

 

 

(2,020)

 

 

 

 

 

 

 

 

Operating profit a

 

 

 

1,379

 

 

1,335

 

 

 

 

 

 

 

Finance income

 

 

13

 

 

30

Finance cost

 

 

(211)

 

 

(188)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit before taxation and exceptional items

 

 

1,181

 

 

1,177

 

 

 

 

 

 

 

Exceptional item - GMP equalisation

7

 

(299)

 

 

-

 

 

 

 

 

 

 

 

Profit before taxation

 

 

 

882

 

 

1,177

 

 

 

 

 

 

 

Taxation

4

 

(144)

 

 

(197)

 

 

 

 

 

 

 

Profit for the year attributable to owners of the parent company

 

 

 

738

 

 

980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted earnings per ordinary share

6

 

29.1p

 

 

38.7p

 

 

 

 

 

 

 

a Operating profit is calculated as profit before net finance costs, exceptional items and taxation.

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

for the year ended 31st March 2019

 

 

 

 

2019

 

 

2018

 

 

 

£000

 

 

£000

 

 

 

 

 

 

 

Profit for the year

 

 

738

 

 

980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Items that will not be reclassified to profit or loss:

 

 

 

 

 

 

Actuarial loss on defined benefit pension scheme

 

 

(933)

 

 

(234)

Deferred taxation on actuarial loss

 

 

159

 

 

40

Deferred taxation on revaluation of assets

 

 

-

 

 

44

 

 

 

(774)

 

 

(150)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total comprehensive income for the year

 

 

(36)

 

 

830

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF FINANCIAL POSITION AT 31st MARCH 2019

 

 

 

 

 

 

2019

 

2018

 

 

£000

 

£000

Non-current assets

 

 

 

 

Intangible assets

 

82

 

85

Property, plant and equipment

 

3,210

 

3,337

Deferred tax asset

 

1,048

 

853

 

 

4,340

 

4,276

 

 

 

 

 

Current assets

 

 

 

 

Inventories

 

3,989

 

3,930

Trade and other receivables

 

2,286

 

2,287

Cash and cash equivalents

 

3,153

 

2,366

 

 

9,428

 

8,583

 

 

 

 

 

Total assets

 

13,768

 

12,859

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

(1,789)

 

(1,474)

Current tax payable

 

(171)

 

(175)

 

 

(1,960)

 

(1,649)

 

 

 

 

 

Non-current liabilities

 

 

 

 

Retirement benefit scheme

 

(7,420)

 

(6,472)

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

(9,380)

 

(8,121)

 

 

 

 

 

Net assets

 

4,388

 

4,738

 

 

 

 

 

Equity

 

 

 

 

Called up share capital

 

254

 

254

Capital redemption reserve

 

109

 

109

Revaluation reserve

 

1,277

 

1,357

Retained earnings

 

2,748

 

3,018

 

 

 

 

 

 

Equity shareholders' funds

 

4,388

 

 

4,738

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31st MARCH 2019

 

 

 

Share

capital

Capital redemption reserve

Revaluation reserve

Retained

earnings

Total

Equity

 

£000

£000

£000

£000

£000

 

 

 

 

 

 

Balance at 31st March 2017

254

109

1,389

2,609

4,361

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(453)

(453)

 

 

 

 

 

 

Profit for the year

-

-

-

980

980

Reclassification of depreciation on revaluation

-

-

(76)

76

-

Other comprehensive income for the year

-

-

44

(194)

(150)

Total comprehensive income for the year

-

-

(32)

862

830

 

 

 

 

 

 

Balance at 31st March 2018

254

109

1,357

3,018

4,738

Total transactions with owners

 

 

 

 

 

Equity dividends paid

-

-

-

(314)

(314)

 

 

 

 

 

 

Profit for the year

-

-

-

738

738

Reclassification of depreciation on revaluation

 

 

(80)

80

-

Other comprehensive income for the year

-

-

-

(774)

(774)

Total comprehensive income for the year

-

-

(80)

44

(36)

 

 

 

 

 

 

Balance at 31st March 2019

254

109

1,277

2,748

4,388

 

 

 

CONSOLIDATED STATEMENT OF CASHFLOWS FOR THE YEAR ENDED 31st MARCH 2019

 

 

 

 

 

 

 

2019

 

2018

 

£000

 

£000

Cash flow from operating activities

 

 

 

 

 

 

 

Profit for the year before taxation

882

 

1,177

 

 

 

 

Adjustments for:

 

 

 

Depreciation

348

 

365

Amortisation

27

 

58

Profit on disposal of property, plant and equipment

(16)

 

(10)

Net finance (income)/cost

17

 

(30)

Defined benefit pension scheme expenses

530

 

237

Contributions to defined benefit pension scheme

(516)

 

(500)

 

 

 

 

 

 

 

 

Operating cash flow before movements in working capital

1,272

 

1,297

 

 

 

 

Changes in working capital:

 

 

 

Increase in inventories

(59)

 

(141)

Decrease/ (increase) in trade and other receivables

6

 

(118)

Increase in trade and other payables

310

 

74

 

 

 

 

Cash generated from operations

1,529

 

1,112

 

 

 

 

Taxation paid

(184)

 

(157)

 

 

 

 

Net cash from operating activities

1,345

 

955

 

 

 

 

Cash flows from investing activities

 

 

 

 

 

 

 

Payments to acquire property, plant and equipment

(239)

 

(222)

Proceeds from the sale of property, plant and equipment

35

 

41

Payments to acquire intangible assets

(23)

 

(64)

Finance (costs)/income

(17)

 

30

 

 

 

 

 

 

 

 

 

(244)

 

(215)

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

Dividends paid

(314)

 

(453)

 

 

 

 

 

(314)

 

(453)

 

 

 

 

 

 

 

 

Net increase in cash and cash equivalents

787

 

287

 

 

 

 

Cash and cash equivalents at beginning of year

2,366

 

2,079

 

 

 

 

Cash and cash equivalents at end of year

3,153

 

2,366

 

 

 

 

 

NOTES TO THE PRELIMINARY ANNOUNCEMENT

 

1. Basis of preparation

 

The Group has prepared its consolidated financial statements for the year ended 31st March 2019 in accordance with International Financial Reporting Standards as adopted by the European Union. There was no impact on the reported results due to the adoption of IFRS 9 and IFRS 15. The accounting policies applied are consistent with those included in the financial statements of the Group for the year ended 31st March 2018 except for changes required on the adoption of IFRS 15 "Revenue from Contracts with Customers" and IFRS 9 "Financial Instruments".

The financial information contained in this preliminary announcement does not constitute the Group's statutory accounts within the meaning of Section 434 of the Companies Act 2006.

The annual report and financial statements for the year ended 31st March 2019 were approved by the Board of Directors on 10th July 2019 along with this preliminary announcement. The annual report and financial statements will be delivered to the Registrar of Companies after the Annual General Meeting.

The statutory accounts of Samuel Heath & Sons PLC for the year ended 31 March 2018 have been delivered to the Registrar of Companies. The auditor's reports on the statutory accounts for the years ended 31st March 2019 and 31st March 2018 were unqualified and did not contain a statement under section 498 of the Companies Act 2006.

2. Critical accounting and key sources of estimation

 

Critical accounting estimates, assumptions and judgements

 

Estimates and judgements are continually evaluated and are based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

 

The Group makes estimates and assumptions concerning the future. The resulting accounting estimates and assumptions will, by definition, seldom equal the related actual results. The Group has evaluated the estimates and assumptions that have been made in relation to the carrying amounts of assets and liabilities in these financial statements.

 

The key accounting judgements and sources of estimation uncertainty with a significant risk of causing a material adjustment to assets and liabilities in the next 12 months include the following:

 

Pensions - movements in equity markets, interest rates and life expectancy could materially affect the level of surpluses and deficits in the defined benefit pension scheme.

 

Valuation of property, plant and equipment - the Group reviews the value, useful economic lives and residual values attributed to assets on an on-going basis to ensure they are appropriate. Changes in market value, economic lives or residual values could impact the carrying value and charges to the income statement in future periods.

 

Provisions - using information available at the balance sheet date, the Directors make judgements based on experience on the level of provision required against assets, including inventory and trade receivables. Further information received after the balance sheet date may impact the level of provision required.

 

Deferred tax assets - deferred tax assets are recognised to the extent that it is probable that taxable profit will be available against which the losses can be utilised. Management judgement is required to determine the amount of deferred tax assets that can be recognised, based upon the likely timing and level of future taxable profits.

 

 

 

 

 

 

 

3. Revenue by geographic market

 

 

 

 

 

 

 

2019

£000

 

2018

£000

 

Overseas

 

 

6,027

 

6,013

Home

 

 

7,866

 

8,341

 

 

 

13,893

 

14,354

4. Income taxes

 

 

2019

£000

 

2018

£000

Current taxes:

 

 

 

Current year

169

 

175

Adjustments in respect of prior periods

(11)

 

(1)

 

180

 

174

Deferred taxes:

 

 

 

Origination and reversal of temporary differences

(36)

 

23

 

 

 

 

Total income taxes

144

 

197

Corporation tax is calculated at 19% (2018: 19%) of the estimated assessable profit for the year.

Tax reconciliation

 

 

2019

£000

 

2018

£000

 

 

Profit for the year

882

 

1,177

 

 

 

 

 

 

Corporation tax charge thereon at 19% (2018: 19%)

168

 

224

 

Adjusted for the effects of:

 

 

 

 

Prior year adjustments

11

 

(1)

 

Research and development claim

(7)

 

(22)

 

Other adjustments

(28)

 

(4)

 

 

 

 

 

 

 

 

 

 

 

Total income taxes

144

 

197

 

 

 

 

 

 

Effective tax rate

16.3%

 

16.7%

5. Dividends

 

2019

 

2018

 

£000

 

£000

 

 

 

 

Final dividend for the year ended 31st March 2018 of 6.875 pence per share (2017: 6.875 pence per share)

174

 

174

 

 

 

 

Interim dividend for the year ended 31st March 2017 of 5.50 pence per share

-

 

139

 

Interim dividend for the year ended 31st March 2019 of 5.50 pence per share (2018: 5.50 pence per share)

 

139

 

139

 

 

 

 

 

313

 

452

 

In addition to the dividends paid during the year the directors are recommending a final dividend for 2019 of 6.875 pence per share amounting to £174,000. The proposed final dividend is subject to approval at the Annual General Meeting and hence has not been included as a liability in these accounts.

6. Earnings per share

The basic and diluted earnings per share are calculated by dividing the relevant profit after taxation of £738,000 (2018: £980,000) by the average number of ordinary shares in issue during the year being 2,534,322 (2018: 2,534,322). The number of shares used in the calculation is the same for both basic and diluted earnings.

 

7. Exceptional item

 

The business has recognised the past service cost resulting from Guaranteed Minimum Pension (GMP) equalisation as an exceptional item on the basis that it is a one off cost of substance arising from a legal case during the financial year.

 

GMP equalisation is the recognition that during the 1990s benefits accrued differently for men and women based on their then different retirement ages.

 

8. Notice of annual general meeting

 

Notice is hereby given that the 2019 Annual General Meeting of the Company will be held at the registered office of the Company, Leopold Street, Birmingham, on 9th August 2019 at 12.00 noon. The final dividend of 6.875 pence, if approved, will be payable on 16th August 2019 to ordinary shareholders registered at close of business on 19th July 2019.

 

9. Posting of accounts

 

The report and accounts are being posted to shareholders today where requested, and are available on the Company's website, at www.samuel-heath.com/investor-relations.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FR SFUFMSFUSELW
Date   Source Headline
1st Apr 20267:00 amRNSDirectorate change
3rd Feb 20263:01 pmRNSRetirement of Director
26th Nov 202512:00 pmRNSHalf-year Report
11th Sep 20252:22 pmRNSResult of AGM
25th Jul 20258:35 amRNSFinal Results & Notice of AGM
4th Feb 20253:15 pmRNSChange of Auditor
26th Nov 20247:00 amRNSHalf-year Report
5th Sep 20244:38 pmRNSResult of AGM
7th Aug 20247:00 amRNSFinal Results
21st Nov 20237:00 amRNSHalf-year Report
7th Sep 20231:53 pmRNSResult of AGM
21st Jul 20237:00 amRNSFinal Results
9th Dec 20221:48 pmRNSHolding(s) in Company
9th Dec 20221:45 pmRNSDirector/PDMR Shareholding
18th Nov 20227:00 amRNSHalf-year Report
25th Aug 20223:08 pmRNSResult of AGM
20th Jul 202212:40 pmRNSReplacement: Final Results
20th Jul 20227:00 amRNSFinal Results
12th Nov 20217:00 amRNSHalf-year Report
6th Aug 20211:35 pmRNSResult of AGM
19th Jul 202110:14 amRNSDirectorate Change
8th Jul 20212:34 pmRNSFinal Results
30th Dec 20207:00 amRNSDirectorate Change
12th Nov 20207:00 amRNSHalf-year Report
7th Aug 20202:35 pmRNSResult of AGM
10th Jul 20207:30 amRNSFinal Results
9th Jul 20204:13 pmRNSHolding(s) in Company
8th Apr 20203:40 pmRNSCOVID-19 Trading Update
6th Feb 20207:00 amRNSDirectorate Change
18th Dec 20197:00 amRNSDirector/PDMR Shareholding
10th Dec 20199:53 amRNSDirectorate Change
15th Nov 20197:00 amRNSHalf-year Report
9th Aug 20192:45 pmRNSResult of AGM
15th Jul 20194:38 pmRNSHolding(s) in Company
11th Jul 20197:00 amRNSFinal Results
1st Apr 201911:47 amRNSPDMR/PCA Dealing
8th Nov 20187:00 amRNSHalf-year Report
10th Aug 20181:01 pmRNSResult of AGM
12th Jul 20183:26 pmRNSFinal Results
15th Jan 201811:13 amRNSDividend Record Date
9th Nov 20177:00 amRNSHalf-year Report
13th Oct 20179:45 amRNSHolding(s) in Company
13th Oct 20179:43 amRNSHolding(s) in Company
29th Sep 20177:00 amRNSDirectorate Change
1st Sep 20179:22 amRNSDirectorate Change
14th Aug 201711:48 amRNSResult of AGM
12th Jul 20179:33 amRNSFinal Results
16th Jun 20177:00 amRNSDirector/PDMR Shareholding - Replacement
10th May 20172:34 pmRNSDirector/PDMR Shareholding
7th Mar 20173:36 pmRNSDirector/PDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.